<DOC>
	<DOCNO>NCT01091818</DOCNO>
	<brief_summary>Dexmedetomidine test midazolam prospective , randomize , double-blind study intensive care child , age 2-17 year . The investigator ' primary hypothesis time end medication extubation short dexmedetomidine sedation .</brief_summary>
	<brief_title>Dexmedetomidine Versus Midazolam Intensive Care Sedation Children</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>informed consent parent age 2 18 year anticipate need respirator treatment 24 hr include study within 48 hrs admission intensive care unit ( ICU ) severe , unstable circulatory failure severe intracranial spinal trauma circulatory instability sever bradycardia atrioventricular ( AV ) block liver failure le 50 % chance anticipated survival know allergy study drug</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>To see sedation dexmedetomidine result faster emergence end intensive care treatment child</keyword>
	<keyword>treatment</keyword>
</DOC>